Collegium Pharmaceutical Inc (COLL) — Capital Reinvestment Ratio
Collegium Pharmaceutical Inc (COLL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($78.44 Million) in capital expenditures ($188.00K). Check Collegium Pharmaceutical Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Collegium Pharmaceutical Inc Capital Reinvestment Ratio (2018–2024)
This chart tracks Collegium Pharmaceutical Inc's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Collegium Pharmaceutical Inc (COLL) cash conversion ratio.
Annual Capital Reinvestment Ratio for Collegium Pharmaceutical Inc (2018–2024)
Year-by-year Capital Reinvestment Ratio for Collegium Pharmaceutical Inc from 2018 to 2024. See COLL free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $204.98 Million | $1.65 Million | ▲ +380.3% |
| 2023 | 0.00x | $274.75 Million | $461.00K | ▼ -87.1% |
| 2022 | 0.01x | $124.23 Million | $1.62 Million | ▼ -30.4% |
| 2021 | 0.02x | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 3.98x | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.23x | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.14x | $169.39 Million | $24.35 Million | — |